Skip NavigationSkip to Content

Induction of apoptosis in human cancer cells by candidaspongiolide, a novel sponge polyketide

  1. Author:
    Trisciuoglio, D.
    Uranchimeg, B.
    Cardellina, J. H.
    Meragelman, T. L.
    Matsunaga, S.
    Fusetani, N.
    Del Bufalo, D.
    Shoemaker, R. H.
    Melillo, G.
  2. Author Address

    Trisciuoglio, Daniela, Uranchimeg, Badarch, Melillo, Giovanni] SAIC Frederick Inc, Tumor Hypoxia Lab, Frederick, MD USA. [Cardellina, John H.; Meragelman, Tamara L.; Shoemaker, Robert H.] NCI, Screening Technol Branch, Dev Therapeut Program, Frederick, MD 21702 USA. [Matsunaga, Shigeki, Fusetani, Nobuhiru] Univ Tokyo, Marine Biochem Lab, Tokyo, Japan. [Trisciuoglio, Daniela, Del Bufalo, Donatella] Regina Elena Inst Canc Res, Expt Chemotherapy Lab, Rome, Italy.
    1. Year: 2008
  1. Journal: Journal of the National Cancer Institute
    1. 100
    2. 17
    3. Pages: 1233-1246
  2. Type of Article: Article
  1. Abstract:

    Background Candidaspongiolide (CAN), a novel polyketide from a marine sponge, is the active component of a mixture that was found to be potently cytotoxic in the National Cancer Institute's 60-cell-line screen. Methods Effects of CAN on U251 glioma and HCT116 colorectal cancer cells and on normal fibroblasts were assessed using radiolabeling studies to measure protein synthesis, clonogenic assays to measure cell survival, flow cytometry of annexin V- and propidium iodide-stained cells to measure apoptosis, and western blots in the presence or absence of specific inhibitors to assess accumulation and phosphorylation of potential downstream target proteins. Results CAN inhibited protein synthesis and potently induced apoptosis in both U251 and HCT116 cells, the latter in part by a caspase 12-dependent pathway. For example, 25%-30% of U251 or HCT116 cells became apoptotic after 24 hours of treatment with 100 nM CAN. CAN also rapidly induced sustained phosphorylation of eukaryotic translation initiation factor-2 (eIF2)-alpha at Ser51 and of the translation elongation factor eEF2 at Thr56, which could contribute to its dose-dependent inhibition of protein synthesis. Stable expression of dominant-negative eIF2 alpha was sufficient to prevent CAN-induced eIF2 alpha phosphorylation and induction of apoptosis but insufficient to prevent inhibition of protein synthesis. CAN induction of eIF2 alpha phosphorylation did not occur by a classic endoplasmic reticulum stress pathway. However, an inhibitor of and small-interfering RNAs to the double-stranded RNA-dependent protein kinase PKR prevented CAN-mediated eIF2 alpha phosphorylation and apoptosis, respectively. Although CAN inhibited protein synthesis in both cancer cells and normal human fibroblasts, it induced eIF2 alpha phosphorylation and apoptosis only in cancer cells. Conclusions CAN triggers PKR/eIF2 alpha/caspase 12-dependent apoptosis and inhibits protein synthesis in cancer cells but only inhibits protein synthesis in normal cells.

    See More

External Sources

  1. PMID: 18728285

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel